Adaptive Biotechnologies ( (ADPT) ) is experiencing volatility. Read on for a possible explanation for the stock’s unusual movement.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Adaptive Biotechnologies’ stock is on the rise due to its promising growth potential in the minimal residual disease detection market and strategic partnerships. Piper Sandler has increased its price target for the company, driven by higher revenue expectations from expanded EMR adoption and clinical trials. Although the company reported a recent quarterly net loss, its revenue has significantly grown compared to last year.
More about Adaptive Biotechnologies
YTD Price Performance: 151.70%
Average Trading Volume: 1,959,739
Technical Sentiment Signal: Buy
Current Market Cap: $2.36B
For further insights into ADPT stock on TipRanks’ Stock Analysis page.
See more of today’s top stock gainers and losers.